INTRODUCTION: The aim of this preliminary report is to demonstrate the efficacy of rapid transcranial magnetic stimulation (rTMS) in the treatment of relapsed major depressive disorder (MDD) patients. METHODS: Four patients with major depressive disorder who were successfully treated with rTMS received a second course of rTMS treatment. Patients were evaluated with the Hamilton Depression Rating Scale - 21 items, the Brief Psychiatric Rating Scale, the Global Depression Scale and the Global Assessment Scale in both trials. The statistical analysis was performed with paired t-tests and chi squares. RESULTS: Clinical ratings demonstrated a significant improvement at the end of both trials. No significant differences were found between the ratings at the end of the treatment courses. CONCLUSION: rTMS was successfully used in the treatment of relapsed MDD patients who had previously responsed to rTMS. ( Int J Psych Clin Pract 2000; 4: 223 - 226).
INTRODUCTION: The aim of this preliminary report is to demonstrate the efficacy of rapid transcranial magnetic stimulation (rTMS) in the treatment of relapsed major depressive disorder (MDD) patients. METHODS: Four patients with major depressive disorder who were successfully treated with rTMS received a second course of rTMS treatment. Patients were evaluated with the Hamilton Depression Rating Scale - 21 items, the Brief Psychiatric Rating Scale, the Global Depression Scale and the Global Assessment Scale in both trials. The statistical analysis was performed with paired t-tests and chi squares. RESULTS: Clinical ratings demonstrated a significant improvement at the end of both trials. No significant differences were found between the ratings at the end of the treatment courses. CONCLUSION: rTMS was successfully used in the treatment of relapsed MDDpatients who had previously responsed to rTMS. ( Int J Psych Clin Pract 2000; 4: 223 - 226).
Entities:
Keywords:
Rapid Transcranial Magnetic Stimulation Relapse Ect Major Depressive Disorder
Authors: Michael S Kelly; Albino J Oliveira-Maia; Margo Bernstein; Adam P Stern; Daniel Z Press; Alvaro Pascual-Leone; Aaron D Boes Journal: J Neuropsychiatry Clin Neurosci Date: 2016-11-30 Impact factor: 2.198